These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 326117)
1. Cis-diamminedichloroplatinum (II). A new anticancer drug. Rozencweig M; von Hoff DD; Slavik M; Muggia FM Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117 [TBL] [Abstract][Full Text] [Related]
2. Cis-platinum: a new anticancer agent. Williams CJ; Whitehouse JM Br Med J; 1979 Jun; 1(6179):1689-91. PubMed ID: 380759 [No Abstract] [Full Text] [Related]
3. [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)]. Osieka R; Schmidt CG Klin Wochenschr; 1979 Dec; 57(23):1249-58. PubMed ID: 121143 [TBL] [Abstract][Full Text] [Related]
4. The role of cis-platinum in solid-tumor therapy. Einhorn LH; Williams SD N Engl J Med; 1979 Feb; 300(6):289-91. PubMed ID: 366407 [No Abstract] [Full Text] [Related]
5. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck. Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332 [TBL] [Abstract][Full Text] [Related]
6. [First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma]. Cavalli F; Sonntag RW; Ryssel HJ; Tschopp L; Brunner KW Schweiz Med Wochenschr; 1976 May; 106(22):754-7. PubMed ID: 996494 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486 [No Abstract] [Full Text] [Related]
8. Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Higby DJ; Wallace HJ; Holland JF Cancer Chemother Rep; 1973; 57(4):459-63. PubMed ID: 4586953 [No Abstract] [Full Text] [Related]
9. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study]. Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191 [TBL] [Abstract][Full Text] [Related]
10. [A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)]. Gallmeier WM; Bruntsch U MMW Munch Med Wochenschr; 1979 May; 121(18):624-7. PubMed ID: 108586 [No Abstract] [Full Text] [Related]
14. Drugs five years later. Cisplatin. Loehrer PJ; Einhorn LH Ann Intern Med; 1984 May; 100(5):704-13. PubMed ID: 6370067 [TBL] [Abstract][Full Text] [Related]
15. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity. Salem P; Khalyl M; Jabboury K; Hashimi L Cancer; 1984 Feb; 53(4):837-40. PubMed ID: 6537893 [TBL] [Abstract][Full Text] [Related]
16. cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies. Sarna G; Skinner DG; Smith RB; Zighelboim J; Goodnight JE; Feig S Cancer Treat Rep; 1980; 64(10-11):1077-82. PubMed ID: 7193086 [TBL] [Abstract][Full Text] [Related]
17. Cis-platinum in the treatment of testicular and other cancers. Williams SD; Einhorn LH Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553 [No Abstract] [Full Text] [Related]
18. [Cisplatin]. Ogawa M Gan To Kagaku Ryoho; 1984 May; 11(5):1140-6. PubMed ID: 6326687 [No Abstract] [Full Text] [Related]
19. Platinum complexes in cancer chemotherapy. Antibiot Chemother (1971); 1978; 23():99-112. PubMed ID: 348089 [TBL] [Abstract][Full Text] [Related]